Brain natriuretic peptide and cardiac autonomic function in type 2 diabetic patients

Diabetes Research and Clinical Practice

Volumn 72, Issue 1, 2006, Pages 12-19

  Yufu, Kunio ^a   Takahashi, Naohiko ^a   Nakagawa, Mikiko ^a   Hara, Masahide ^a   Saikawa, Tetsunori ^a   Yoshimatsu, Hironobu ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

123I metaiodobenzylguanidine scintigraphic findings; Baroreflex sensitivity; Brain natriuretic peptide; Diabetes

Indexed keywords

(3 IODOBENZYL)GUANIDINE; BRAIN NATRIURETIC PEPTIDE; METAIODOBENZYLGUANIDINE I 123; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; AUTONOMIC INNERVATION; CONTROLLED STUDY; FEMALE; HEART DISEASE; HEART FUNCTION; HEART RATE VARIABILITY; HEART SCINTISCANNING; HORMONE BLOOD LEVEL; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARASYMPATHETIC INNERVATION; PRESSORECEPTOR REFLEX;

3-IODOBENZYLGUANIDINE; ADULT; AGED; AUTONOMIC NERVOUS SYSTEM; BAROREFLEX; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; ECHOCARDIOGRAPHY; FEMALE; HEART; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; IODINE RADIOISOTOPES; LIPIDS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN;

EID: 33645323517     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2005.08.011     Document Type: Article

References (31)

1. T.B. Levin, G.S. Francis, S.R. Goldsmith, A.B. Simon, and J.N. Cohn Activity of the sympathetic nervous system and renin angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure Am. J. Cardiol. 49 1981 1659 1666
2. H. Tsuji, F.J. Venditti Jr., E.S. Manders, J.C. Evans, M.G. Larson, and C.L. Feldman Reduced heart rate variability and mortality risk in an elderly cohort Circulation 90 1994 878 883
3. H. Tsuji, M.G. Larson, F.J. Venditti Jr., E.S. Manders, J.C. Evans, and C.L. Feldman Impact of reduced heart rate variability on risk for cardiac events Circulation 94 1996 2850 2855
4. T.E.J. Bigger, J.L. Fleiss, R.C. Steinman, L.M. Rolnitzky, R.E. Kleiger, and J.N. Rottman Frequency domain measures of heart period variability and mortality after myocardial infarction Circulation 85 1992 164 171
5. M.T. La Rovere, G. Specchia, A. Mortara, and P.J. Schwartz Baroreflex sensitivity, clinical correlates and cardiovascular mortality among patients with a first myocardial infarction: a prospective study Circulation 78 1988 816 824
6. M.T. La Rovere, J.T. Bigger Jr., F.I. Marcus, A. Mortara, and P.J. Schwartz Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction Lancet 351 1998 478 484
7. W. Rathmann, D. Ziegler, M. Jahnke, B. Haastert, and F.A. Gries Mortality in diabetic patients with cardiovascular autonomic neuropathy Diab. Med. 10 1993 664 671
8. P. Reichard, and M. Phil Mortality and treatment side effects during long term intensified conventional insulin treatment in the Stockholm Diabetes Intervention Study Diabetes 43 1994 313 317
9. M.R. Wilkins, J. Redondo, and L.A. Brown The natriuretic-peptide family Lancet 349 1997 1307 1310
10. K. Nakao, Y. Ogawa, S. Suga, and H. Imura Molecular biology and biochemistry of the natriuretic peptide system. I. Natriuretic peptides J. Hypertens 10 1992 907 912
11. H. Yasue, M. Yoshimura, H. Sumida, K. Kikuta, K. Kugiyama, and M. Jougasaki Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure Circulation 90 1994 195 203
12. C.M. Wei, D.M. Heublein, M.A. Perrella, A. Lerman, R.J. Rodeheffer, and C.G. McGregor Natriuretic peptide system in human heart failure Circulation 88 1993 1004 1009
13. T. Tsutamoto, A. Wada, K. Maeda, T. Hisanaga, Y. Maede, and D. Fukai Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction Circulation 96 1997 509 516
14. M.R. Cowie, A.D. Struthers, D.A. Wood, A.J. Coats, S.G. Thompson, and P.A. Poole-Wilson Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care Lancet 350 1997 1349 1353
15. T.A. McDonagh, S.D. Robb, D.R. Murdoch, J.J. Morton, I. Ford, and C.E. Morrison Biochemical detection of left-ventricular systolic dysfunction Lancet 351 1998 9 13
16. C.J. Thomas, G.A. Head, and R.L. Woods Similar baroreflex bradycardic actions of atrial natriuretic peptide and B and C types of natriuretic peptides in conscious rats J. Hypertens. 17 1999 801 806
17. V. Spallone, and G. Menzinger Diagnosis of cardiovascular autonomic neuropathy in diabetes Diabetes 46 1997 S67 S76
18. I.S.R. Martina, R. van Koningsveld, P.I.M. Schmitz, F.G.A. van der Meche, and P.A. van Doorn Measuring vibration threshold with a graduated tuning fork in normal aging and in patients with polyneuropathy J. Neurol. Neurosurg. Psychiatry 65 1998 743 747
19. N. Hotta, K. Sugiyama, I. Tsuchida, T. Sano, N. Koh, and H. Matsumae Use of the C64 quantitative Tuning fork and the effect of niceritrol in diabetic neuropathy Clin. Ther. 16 1994 1007 1015
20. Y. Yano, A. Katsuki, E.C. Gabazza, K. Ito, M. Fujii, and M. Furuta Plasma brain natriuretic peptide levels in normotensive noninsulin-dependent diabetic patients with microalbuminuria J. Clin. Endocrinol. Metab. 84 1999 2353 2356
21. J. Koglin, S. Pehlivanli, M. Schwaiblmair, M. Vogeser, P. Cremer, and W. von Scheidt Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure J. Am. Coll. Cardiol. 38 2001 1934 1941
22. R.B. Devereux, D.R. Alonso, E.M. Lutas, G.J. Gottlieb, E. Campo, and I. Sachs Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings Am. J. Cardiol. 67 1986 450 458
23. N. Takahashi, M. Nakagawa, T. Saikawa, T. Ooie, T. Akimitsu, and K. Kaneda Noninvasive assessment of the cardiac baroreflex: response to downward tilting and comparison with the phenylephrine method J. Am. Coll. Cardiol. 34 1999 211 215
24. N. Takahashi, M. Nakagawa, T. Saikawa, T. Ooie, K. Yufu, and S. Shigematsu Effect of essential hypertension on cardiac autonomic function in type 2 diabetic patients J. Am. Coll. Cardiol. 38 2001 232 237
25. M. Nakagawa, N. Takahashi, K. Yufu, T. Fujino, T. Ooie, and H. Yonemochi Malignant neurocardiogenic vasovagal syncope associated with chronic exaggerated vagal tone PACE 23 2000 1695 1697
26. D.L. Eckberg, M. Drabinsky, and E. Braunward Defective cardiac parasympathetic control in patients with heart disease N. Engl. J. Med. 285 1971 877 883
27. D.S. Amorim, H.D. Dargie, K. Heer, M. Brown, D. Jenner, and E.G.J. Olsen Is there autonomic impairment in congestive (dilated) cardiomyopathy? Lancet 1 1981 525 527
28. C.B. Higgins, S.F. Vatner, D.L. Eckberg, and E. Braunward Alterations in the baroreceptor reflex in conscious dogs with heart failure J. Clin. Invest. 51 1972 715 724
29. W. Qi, P. Mathisen, J. Kjekshus, S. Simonsen, R. Bjørnerheim, and K. Endresen Natriuretic peptides in patients with aortic stenosis Am. Heart J. 142 2001 725 732
30. A. Frattola, G. Parati, P. Gamba, F. Paleari, G. Mauri, and M.D. Rienzo Time and frequency domain estimates of spontaneous baroreflex sensitivity provide early detection of autonomic dysfunction in diabetes mellitus Diabetologia 40 1997 1470 1475
31. K. Sakata, M. Shirotani, H. Yoshida, and C. Kurata Comparison of effects of enalapril and nitrendipine on cardiac sympathetic nervous system in essential hypertention J.